'World Multiple Sclerosis Day' is on May 3oth. The day is meant to highlight the disease that has no cure and its effects on the millions of people who live with the condition. Officials with the ...

Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with ...

Health Minister Michael Damianos delivered a speech on the occasion of World Multiple Sclerosis Day on Friday, emphasising ...

Early diagnosis and treatment aim to minimise the impact of multiple sclerosis on their daily lives and extend their ...

Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), | Roche has ...

Multiple Sclerosis cases are rising in India, especially among women, with experts stressing early diagnosis, access to ...

Coinciding with World Multiple Sclerosis (MS) Day, observed annually on 30th May, the Zayed Higher Organisation for People of ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...